Early outcomes favorable among transplant recipients whose donors had COVID-19
Click Here to Manage Email Alerts
In the third installment of a three-part video series, Heather Stefanski, MD, PhD, discusses the impact of COVID-19 on the National Marrow Donor Program/Be The Match.
“One of the common questions we received ... is what to do when a donor tests positive for COVID-19,” Stefanski — vice president of medical services for National Marrow Donor Program/Be The Match — told Healio.
Researchers evaluated post-transplant survival and outcomes among patients who received a product from a donor who had tested positive for COVID-19 and had outcomes reported to Center for International Blood and Marrow Transplant Research.
In this video, Stefanski provides an overview of the favorable early outcomes observed.
Click here to see the first installment of the video series in which Stefanski highlights the lack of equality in access to potentially lifesaving transplant based on ethnicity and recent research efforts designed to mitigate the impact of HLA mismatches.
Click here to see the second installment of the series in which Stefanski discusses the role of umbilical cord blood as a stem cell source.
Collapse
Healio Interview
Click Here to Manage Email Alerts